BM
BMGL.US Basel Medical Group Ltd Ordinary Shares
- Market cap
- USD 6.38M
- P/E
- -
- P/B
- 1.89x
- ROE
- -40.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Sep 2026.
Is BMGL.US undervalued?
Graham numberThe Graham number of Basel Medical Group Ltd Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Basel Medical Group Ltd Ordinary Shares fundamental analysis
No fundamental analysis for Basel Medical Group Ltd Ordinary Shares yet.
Basel Medical Group Ltd Ordinary Shares stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman's health, and general practice services. In addition, the company's services inc…
Full company profileBasel Medical Group Ltd Ordinary Shares financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Basel Medical Group Ltd Ordinary Shares annual financial statements
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 10.7M | 9.70M | 10.1M | 11.3M | 21.5M | 26.2M |
| Gross Profit | 8.48M | 7.36M | 7.80M | 8.79M | 8.34M | 15.1M |
| Operating Income | 2.47M | 2.00M | 2.20M | -2.18M | 8.33M | 15.1M |
| EBITDA | 3.28M | 2.93M | 3.11M | -11.1M | -440K | 4.27M |
| Net Income | 1.98M | 1.78M | 2.07M | -12.1M | -748K | -2.03M |
| EPS | 1.46 | 1.32 | 1.53 | -7.72 | -0.47 | -1.27 |
| Balance Sheet | ||||||
| Total Assets | 16.8M | 15.4M | 16.3M | 16.9M | 17.8M | 17.8M |
| Total Liabilities | 13.1M | 9.89M | 8.75M | 12.0M | 13.3M | 13.3M |
| Shareholders' Equity | 3.71M | 5.49M | 7.56M | 4.86M | 5.06M | 5.06M |
| Cash & Short-term Investments | 1.56M | 1.22M | 1.95M | 2.98M | 530K | 530K |
| Total Debt | 10.2M | 7.21M | 4.29M | 3.42M | 9.62M | 9.62M |
| Cash Flow | ||||||
| Operating Cash Flow | 2.79M | 2.60M | 2.51M | -4.34M | -635K | 3.97M |
| Capital Expenditure | 88.5K | 6.16K | 7.92K | 54.8K | 248K | 246K |
| Free Cash Flow | 2.70M | 2.59M | 2.50M | -4.40M | -883K | 1.76M |
| Ratios | ||||||
| ROE | 53.4% | 32.5% | 27.4% | -248.7% | -14.8% | -40.2% |
| ROA | 11.7% | 11.6% | 12.7% | -71.7% | -4.2% | -11.4% |
| Net Profit Margin | 18.6% | 18.4% | 20.6% | -106.8% | -3.5% | -7.8% |
| Debt to Equity | 2.74x | 1.31x | 0.57x | 0.70x | 1.90x | 1.90x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Basel Medical Group Ltd Ordinary Shares dividends
Basel Medical Group Ltd Ordinary Shares has not paid dividends in the last 5 fiscal years.
Last stock split: 1:12 on Jun 22, 2026.
Who owns Basel Medical Group Ltd Ordinary Shares
- Insiders 6.26%
- Institutions 0.01%
- Public & others 93.73%
- Shares outstanding 13.6M
- Free float 523K
Top funds holding BMGL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 582.00 | 0.04% | 0.00% | Aug 2026 |
Top institutions holding BMGL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| UBS Group AG | 495.00 | 0.03% | -54.50% | Jun 2026 |
| Coston, McIsaac & Partners | 4.00 | 0.00% | 0.00% | Jun 2026 |
| T3 Companies, LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| XTX Topco Ltd | 0.00 | 0.00% | -100.00% | Jun 2026 |
Basel Medical Group Ltd Ordinary Shares company profile
- Company name
- Basel Medical Group Ltd Ordinary Shares
- Ticker
- BMGL.US
- ISIN
- VGG0864B1114
- Exchange
- USA Stocks
- Listed since
- Feb 25, 2025
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 82
- Fiscal year end
- June
- Address
- Gleneagles Medical Centre, Singapore, Singapore, 258499
- Phone
- 65 6291 9188
- Website
- baselmedical.com
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments. It also provides health screening, mental health, woman's health, and general practice services. In addition, the company's services include consultation, medical diagnosis, and medical and surgical treatments. Basel Medical Group Ltd was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd Ordinary Shares management
3- Dr. Yen Feng Chhoa M.D.Chief Executive Officer · born 1987
- Mr. Chun How NeoGroup Chief Financial Officer · born 1985
- Mr. Boon Chye TanChief Commercial Officer · born 1981